Recruiting NA INTERVENTIONAL 1-arm NCT04754087

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation

Sponsor: Zimmer Biomet

Conditions Avascular Necrosis of Hip Degenerative Joint Disease of Hip Fracture of Hip Fractures, Hip Osteoarthritis of Hip Osteoarthritis, Hip Rheumatoid Arthritis of Hip Total Hip Arthroplasty

Interventions Vivacit-E and Longevity (HXLPE) Liners

Updated 11 times since 2021 Last updated: Jun 13, 2025 Started: Jul 7, 2021 Primary completion: Dec 31, 2033 Completion: Dec 31, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04754087, this NA trial focuses on Avascular Necrosis of Hip and Degenerative Joint Disease of Hip and remains actively recruiting participants. Sponsored by Zimmer Biomet, it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Jul 2025 — Present [monthly]

Recruiting NA
Nov 2024 — Jul 2025 [monthly]

Recruiting NA
Sep 2024 — Nov 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA

▶ Show 6 earlier versions

May 2023 — Jan 2024 [monthly]

Recruiting NA
Nov 2022 — May 2023 [monthly]

Recruiting NA
Feb 2022 — Nov 2022 [monthly]

Recruiting NA
Oct 2021 — Feb 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Mar 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zimmer Biomet

Data source: Zimmer Biomet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bournemouth, United Kingdom , Denver, United States , Durham, United States , Eugene, United States , Geleen, Netherlands , Hengelo, Netherlands , Hvidovre, Denmark , Lund, Sweden , Portland, United States , Salt Lake City, United States and 1 more location